Acadia Healthcare (ACHC, Financial) experienced a notable stock decline, dropping 5.06% to $56.32 per share with a trading volume of 1.06679 million shares. The stock showed a turnover rate of 1.15% and a fluctuation range of 6.36%.
Recent financial reports indicate the company achieved a revenue of $796 million and a net profit of $78.48 million, with an earnings per share of $0.86. The company reported a gross profit of $191 million but has a negative price-to-earnings ratio of 709.38.
In terms of institutional ratings, among the 14 rating firms, 71% recommended buying the stock, while 29% suggested holding it, and none advised selling.
Within the broader healthcare facilities industry, the overall increase was 1.80%. Notably, stocks such as Kindly Md, Inc., Newgenivf Group Limited, and The Oncology Institute, Inc. saw significant growth. Newgenivf Group Limited and Kindly Md, Inc. were active, with turnover rates of 66.01% and 11.38%, respectively. Stocks like Kindly Md Inc C/Wts and Newgenivf Group Limited also exhibited high volatility, with amplitude rates of 46.26% and 40.68%.
Acadia Healthcare specializes in acquiring and developing behavioral healthcare facilities in the U.S., U.K., and Puerto Rico. Most of its revenue in the U.S. is driven by acute inpatient psychiatric hospitals and specialty treatment facilities, largely funded by Medicaid and commercial payers. In the U.K., the National Health Service is the primary revenue source for its facilities.
